The latest announcement is out from Rhythm Biosciences Ltd. ( (AU:RHY) ).
Rhythm Biosciences Ltd. has announced the application for the quotation of new securities on the Australian Securities Exchange (ASX). The company is set to quote 33,333,331 options expiring on March 31, 2026, as part of previously announced transactions. This move could potentially enhance the company’s financial flexibility and support its ongoing projects in the biotechnology sector.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development of diagnostic technologies. The company is known for its work on innovative cancer detection solutions, aiming to improve early diagnosis and patient outcomes.
YTD Price Performance: -22.22%
Average Trading Volume: 310,368
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$20.29M
For an in-depth examination of RHY stock, go to TipRanks’ Stock Analysis page.